Clinical Trials for Binhui Biopharmaceutical

Explore 9 clinical trials worldwide

Showing 1-9 of 9 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Binhui Biopharmaceutical

Clinical Trials (9)

NCT05954091
OH2 Administered by Intratumoral Injection
PHASE1Not yet recruiting
29 participants
Started: Sep 1, 2025 · Completed: Jan 1, 2028
1 condition1 sponsor0 locations
NCT05938296
OHSV2-PD-L1/CD3-BsAb Administered Via Intratumoral Injection
PHASE1Recruiting
29 participants
Started: Dec 19, 2023 · Completed: Jan 1, 2026
1 condition1 sponsor2 locations
NCT05698459
OH2 Oncolytic Viral Therapy Via Transcatheter Intraarterial Infusion in Patients with Advanced Liver Cancer
PHASE1Recruiting
12 participants
Started: May 5, 2023 · Completed: Jan 31, 2026
1 condition1 sponsor1 location
NCT05868707
OH2 Injection in Melanoma
PHASE3Recruiting
340 participants
Started: Mar 8, 2023 · Completed: Mar 31, 2027
1 condition1 sponsor30 locations
NCT05232136
OH2 Oncolytic Viral Therapy in Non-Muscle-Invasive Bladder Cancer
PHASE1/PHASE2Recruiting
30 participants
Started: Jul 11, 2022 · Completed: Oct 31, 2025
1 condition1 sponsor1 location
NCT05235074
OH2 Oncolytic Viral Therapy in Central Nervous System Tumors
PHASE1/PHASE2Recruiting
28 participants
Started: Nov 16, 2021 · Completed: Jun 16, 2026
1 condition1 sponsor1 location
NCT04616443
OH2 Injection in Combination With HX008 for Melanoma.
PHASE1/PHASE2Recruiting
60 participants
Started: Dec 1, 2020 · Completed: Nov 30, 2025
1 condition1 sponsor1 location
NCT03866525
OH2 Oncolytic Viral Therapy in Solid Tumors
PHASE1/PHASE2Recruiting
300 participants
Started: Apr 2, 2019 · Completed: Aug 30, 2025
2 conditions1 sponsor1 location
NCT04386967
OH2 Injection in Solid Tumors
PHASE1/PHASE2Recruiting
30 participants
Started: Nov 22, 2018 · Completed: Dec 13, 2026
2 conditions1 sponsor1 location